Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Respiratory dysfunction in burned patients].

L Bargues1, F Vaylet, H Le Bever

  • 1Centre de Traitement des Brûlés, Hôpital d'Instruction des Armées Percy, Clamart, France. BARGOL@aol.com

Revue Des Maladies Respiratoires
|October 18, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical and molecular characteristics of non-small-cell lung cancer (NSCLC) harboring EGFR mutation: results of the nationwide French Cooperative Thoracic Intergroup (IFCT) program.

Annals of oncology : official journal of the European Society for Medical Oncology·2017
Same author

[Not Available].

Annals of burns and fire disasters·2015
Same author

[Not Available].

Annals of burns and fire disasters·2015
Same author

[Mycobacterial pulmonary infection due to Mycobacterium simiae].

Revue des maladies respiratoires·2015
Same author

Epidemiology of filamentous fungal infections in burned patients: A French retrospective study.

Burns : journal of the International Society for Burn Injuries·2015
Same author

Cryptococcosis in sarcoidosis: cryptOsarc, a comparative study of 18 cases.

QJM : monthly journal of the Association of Physicians·2013
Same journal

[French version of the guidelines for connective tissue disease-associated ILD].

Revue des maladies respiratoires·2026
Same journal

[Pulmonary expression of an asymptomatic lysosomal storage disorder].

Revue des maladies respiratoires·2026
Same journal

[Factors associated with FEV1 evolution in cystic fibrosis patients treated by CFTR modulator tritherapy].

Revue des maladies respiratoires·2026
Same journal

[Subacute pulmonary coccidioidomycosis: A differential diagnosis of lung cancer].

Revue des maladies respiratoires·2026
Same journal

[Relevance of the ACT score in severe asthma with obesity: A pilot study].

Revue des maladies respiratoires·2026
Same journal

[Automated analysis of mandibular movements for the screening of obstructive sleep apnea].

Revue des maladies respiratoires·2026
See all related articles

Smoke inhalation causes severe complications in burn patients, leading to significant mortality. Understanding the inflammatory response is key to future treatments for inhalation injury.

Area of Science:

  • Burn injury research
  • Respiratory medicine
  • Toxicology

Background:

  • Smoke inhalation is a primary cause of mortality in severely burned patients.
  • Respiratory complications, including pneumonitis and ARDS, are common.
  • Tracheal stenosis is a potential late complication of mechanical ventilation.

Purpose of the Study:

  • To summarize the respiratory complications associated with smoke inhalation in burn patients.
  • To highlight the pathophysiological mechanisms involved in smoke inhalation injury.
  • To discuss potential future therapeutic strategies.

Main Methods:

  • Clinical diagnosis based on history and physical examination.
  • Bronchoscopic confirmation of injury.
  • Review of existing clinical and experimental studies.

Related Experiment Videos

Main Results:

  • Damage to the mucosal barrier and inflammatory mediator release are critical in smoke inhalation.
  • Advances in ventilation have reduced barotrauma and infectious complications.
  • Inhalation injury leads to severe respiratory and systemic complications.

Conclusions:

  • Inhalation injury significantly impacts burn patient outcomes.
  • Inflammation plays a central role in the pathophysiology.
  • Modulating the inflammatory response may offer future treatment avenues.